SURGICAL INNOVATIONS GROUP PLC (SUN) — Full Year Results

Investor webinar replay

Replay transcript excerpt

Good morning, and welcome to the SURGICAL INNOVATIONS GROUP PLC investor presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged and could be submitted at any time via the q and a tab situated on the right hand corner of your screen. Simply type in your questions and press send. The company may not be in a position to answer every question it receives during the meeting itself. However, the company can review all questions submitted today and publish responses where it's appropriate to do so. Before we begin, I'd like to submit the following poll. I'd now like to hand you over to David Marsh, CEO. Good morning, sir. Good morning, everybody, and welcome to our, surgical innovations presentation for the year end results for 2025. Thank you very much for taking the time to join us. We'll start our presentation looking at our 2025 results, and where the impact of, how that affected the business. Let's move the slides forward. So in 2025, we delivered revenues of 11.6, which were broadly flat for the year. And that was in part due to some headwinds we faced, but it also masked a number of important positives that the business achieved throughout the year. For example, in Europe, we demonstrated very strong growth, 23%, and that was based on our the on our sustainability messaging, which continues to resonate and is actually growing in key markets like The UK and and European market as well. And it's interesting to see that as tenders come up, sustainability is becoming more and more of a key feature of those tenders. And so we're helping a lot of our partners to write those tendered responses, and we're beginning to see some some successes there. UK third party sales grew by 14%, and this is particularly impress...